New York, New York (PRWEB) May 17, 2013
Stryker hip lawsuit claims filed on behalf of alleged victims of last year’s Rejuvenate and ABG II Modular-Neck Hip Stem recall continue to move forward in New Jersey Superior Court, Bernstein Liebhard LLP reports. According to court documents, a Case Management Conference was held in the Stryker hip recall litigation on May 15th, at which time the Court, among other things, set deadlines by which Plaintiffs with cases now pending in the litigation must submit Fact Sheets to Defendant and Liaison Counsel. The Court also scheduled the Stryker hip litigation’s next Case Management Conference for June 18, 2013. (In re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)
“We continue to hear from Stryker hip replacement patients who have allegedly suffered serious complications related to the Rejuvenate and ABG II recall. We expect to see substantial progress in this litigation in the coming months,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is actively filing Stryker hip lawsuits in the New Jersey litigation, and continues to offer free legal evaluations to individuals affected by the Stryker Rejuvenate and ABG II hip recall.
Stryker Hip Recall
The Stryker hip recall was announced in July 2012, after the Rejuvenate and ABG II hip stems were found to be prone to fretting and corrosion at the modular neck junction. The Company has advised recipients of Rejuvenate and ABG II hip stems to undergo blood tests for elevated metal ion levels and cross sectional imaging to ensure the components are functioning properly, even in the absence of symptoms. According to Stryker, some 20,000 Rejuvenate and ABG II hip stems were sold prior to the announcement of the Stryker hip recall.*
Court documents indicate that at least 145 Stryker hip lawsuits have already been filed in the New Jersey litigation. Plaintiffs allege that metal particles shed from the Stryker hip replacements caused local tissue reactions manifesting with pain and/or swelling, and other adverse outcomes including metallosis, necrosis and osteolysis. Last month, Bergen County Superior Court Judge Brian R. Martinotti set forth procedures for the parties to begin selecting Stryker hip lawsuits for early mediation. However, his order stipulated that the case against Stryker will continue while mediation takes place.
Plaintiffs in federally-filed Stryker hip lawsuits have petitioned the U.S. Judicial Panel on Multidistrict Litigation (JPML) to establish a consolidated proceeding for those claims in a single federal court. The Panel has announced that it will hear Oral Arguments on the matter on May 30th. (In Re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, Case Pending No. 20 (JPML))
Individuals allegedly affected by the Stryker hip recall for Rejuvenate and ABG II hip stems may be entitled to compensation for medical bills, lost wages, and pain and suffering. Further information regarding Stryker hip lawsuits is available at Bernstein Liebhard LLP’s website. To learn more, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP